DEPDC1B Antikörper (AA 451-529)
Kurzübersicht für DEPDC1B Antikörper (AA 451-529) (ABIN2808264)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 451-529
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat,Cow,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human DEPDC1B
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
-
: "High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer." in: Oncology letters, Vol. 16, Issue 5, pp. 6749-6755, (2018) (PubMed).
: "High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer." in: Oncology letters, Vol. 14, Issue 6, pp. 6801-6808, (2017) (PubMed).
-
: "High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer." in: Oncology letters, Vol. 16, Issue 5, pp. 6749-6755, (2018) (PubMed).
-
- DEPDC1B (DEP Domain Containing 1B (DEPDC1B))
-
Andere Bezeichnung
- DEPDC1B
-
Hintergrund
-
Synonyms: XTP1, BRCC3, DEP domain-containing protein 1B, HBV X-transactivated gene 8 protein, HBV XAg-transactivated protein 8, DEPDC1B, XTP8
Background: GTPase activator activity.
-
Gen-ID
- 55789
-
UniProt
- Q8WUY9
Target
-